Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cordes

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|November 16, 2005
Caspases target only two architectural components within the core structure of the nuclear pore complexMonika Patre, Anja Tabbert, Daniela Hermann, et al.
European Journal of Medical Research|November 15, 2000
HIV-related nontuberculous mycobacterial infection: incidence, survival analysis and associated risk factorsK N Arastéh, C Cordes, M Ewers, et al.
The Journal of Cell Biology|July 10, 2002
The cytoplasmic filaments of the nuclear pore complex are dispensable for selective nuclear protein importTobias C Walther, Helen S Pickersgill, Volker C Cordes, et al.
HIV Medicine|February 12, 2009
Implications of and perspectives on HIV surveillance using a serological method to measure recent HIV infections in newly diagnosed individuals: results from a pilot study in Berlin, Germany, in 2005-2007J Bätzing-Feigenbaum, S Loschen, S Gohlke-Micknis, et al.
European Journal of Medical Research|July 2, 2011
Acute hepatitis C in persons infected with the human immunodeficiency virus (HIV): the "real-life setting" proves the conceptM Obermeier, P Ingiliz, L Weitner, et al.
Nature Biotechnology|November 7, 2022
MINSTED nanoscopy enters the Ångström localization rangeMichael Weber, Henrik von der Emde, Marcel Leutenegger, et al.
HIV Medicine|December 6, 2011
Twenty-four-week efficacy and safety of switching virologically suppressed HIV-1-infected patients from nevirapine immediate release 200 mg twice daily to nevirapine extended release 400 mg once daily (TRANxITION)K Arasteh, D Ward, A Plettenberg, et al.
HIV Medicine|January 26, 2018
Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?J Bischoff, S Mauss, C Cordes, et al.
The EMBO Journal|July 24, 2021
Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodiesThomas Güttler, Metin Aksu, Antje Dickmanns, et al.
Clinical Research in Cardiology Supplements|February 18, 2016
[Rehabilitation standards for follow-up treatment and rehabilitation of patients with ventricular assist device (VAD)]Detlev Willemsen, C Cordes, B Bjarnason-Wehrens, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|November 16, 2005
Caspases target only two architectural components within the core structure of the nuclear pore complexMonika Patre, Anja Tabbert, Daniela Hermann, et al.
European Journal of Medical Research|November 15, 2000
HIV-related nontuberculous mycobacterial infection: incidence, survival analysis and associated risk factorsK N Arastéh, C Cordes, M Ewers, et al.
The Journal of Cell Biology|July 10, 2002
The cytoplasmic filaments of the nuclear pore complex are dispensable for selective nuclear protein importTobias C Walther, Helen S Pickersgill, Volker C Cordes, et al.
HIV Medicine|February 12, 2009
Implications of and perspectives on HIV surveillance using a serological method to measure recent HIV infections in newly diagnosed individuals: results from a pilot study in Berlin, Germany, in 2005-2007J Bätzing-Feigenbaum, S Loschen, S Gohlke-Micknis, et al.
European Journal of Medical Research|July 2, 2011
Acute hepatitis C in persons infected with the human immunodeficiency virus (HIV): the "real-life setting" proves the conceptM Obermeier, P Ingiliz, L Weitner, et al.
Nature Biotechnology|November 7, 2022
MINSTED nanoscopy enters the Ångström localization rangeMichael Weber, Henrik von der Emde, Marcel Leutenegger, et al.
HIV Medicine|December 6, 2011
Twenty-four-week efficacy and safety of switching virologically suppressed HIV-1-infected patients from nevirapine immediate release 200 mg twice daily to nevirapine extended release 400 mg once daily (TRANxITION)K Arasteh, D Ward, A Plettenberg, et al.
HIV Medicine|January 26, 2018
Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?J Bischoff, S Mauss, C Cordes, et al.
The EMBO Journal|July 24, 2021
Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodiesThomas Güttler, Metin Aksu, Antje Dickmanns, et al.
Clinical Research in Cardiology Supplements|February 18, 2016
[Rehabilitation standards for follow-up treatment and rehabilitation of patients with ventricular assist device (VAD)]Detlev Willemsen, C Cordes, B Bjarnason-Wehrens, et al.
Pageof 7